Symbol="OCUP"
AssetType="Common Stock"
Name="Ocuphire Pharma Inc"
Description="Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of various eye disorders. The company is headquartered in Farmington Hills, Michigan."
CIK="1228627"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="15245 SHADY GROVE ROAD, SUITE 455, ROCKVILLE, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="86950000"
EBITDA="18607000"
PERatio="4.511"
PEGRatio="None"
BookValue="1.969"
DividendPerShare="0"
DividendYield="0"
EPS="0.92"
RevenuePerShareTTM="2.035"
ProfitMargin="0.449"
OperatingMarginTTM="0.447"
ReturnOnAssetsTTM="0.353"
ReturnOnEquityTTM="0.639"
RevenueTTM="41599000"
GrossProfitTTM="-14584000"
DilutedEPSTTM="0.92"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="20.2"
TrailingPE="4.511"
ForwardPE="-"
PriceToSalesRatioTTM="92.17"
PriceToBookRatio="5.4"
EVToRevenue="52.97"
EVToEBITDA="-2.01"
Beta="0.105"
num_52WeekHigh="6.6"
num_52WeekLow="1.81"
num_50DayMovingAverage="3.998"
num_200DayMovingAverage="3.731"
SharesOutstanding="20952200"
DividendDate="2020-11-06"
ExDividendDate="None"
symbol="OCUP"
open="4.05"
high="4.35"
low="4.04"
price="4.33"
volume="174291.00"
latest_trading_day="2023-07-31"
previous_close="4.02"
change="0.31"
change_percent="7.7114%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="28"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="72"
Volume_recent_avg="294901"
Change_recent_avg="0.01"
Delta_recent_avg="0.34"
Variance_recent_avg="0.17"
Change_ratio_recent_avg="-0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="72"
Aroon_momentum_negative="28"
image_negative_thumbnail_id_1="498"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0107.jpeg"
image_negative_thumbnail_id_2="1088"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_neutral_thumbnail_id_1="587"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="688"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_positive_thumbnail_id_2="651"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0057.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
